Though the exact pathways leading to PD-L1 regulation by class II HDACs have not been fully elucidated, data derived from studies in pancreatic cancer demonstrate that HDAC5 negatively regulates PD-L1 expression via interaction with NF-κΒ p65. This evidence concerns the gene HDAC5 and pancreatic neoplasm.